BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16428487)

  • 1. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
    Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
    J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
    J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.
    Fafi-Kremer S; Brengel-Pesce K; Barguès G; Bourgeat MJ; Genoulaz O; Seigneurin JM; Morand P
    J Clin Virol; 2004 Jun; 30(2):157-64. PubMed ID: 15125872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
    Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
    J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma.
    Pajand O; Pourakbari B; Mahjob F; Aghamohammadi A; Mamishi N; Mamishi S
    Pediatr Hematol Oncol; 2011 Feb; 28(1):10-5. PubMed ID: 21083364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.
    Jones K; Nourse JP; Keane C; Crooks P; Gottlieb D; Ritchie DS; Gill D; Gandhi MK
    Am J Hematol; 2012 Mar; 87(3):258-65. PubMed ID: 22213215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free epstein-barr viral loads in childhood hodgkin lymphoma: a study from South India.
    Sinha M; Rao CR; Shafiulla M; Appaji L; Bs AK; Sumati BG; Avinash T; Jayshree RS
    Pediatr Hematol Oncol; 2013 Sep; 30(6):537-43. PubMed ID: 23756088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
    Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
    Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative PCR in EBV-infected renal transplant patients.
    Merlino C; Cavallo R; Bergallo M; Giorgi S; Forgnone F; Re D; Sinesi F; Musso T; Negro Ponzi A
    New Microbiol; 2001 Jul; 24(3):223-9. PubMed ID: 11497078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
    Tan EL; Looi LM; Sam CK
    Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
    Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
    J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.